- Home
- OESX vs CYCC Comparison
OESX vs CYCC Comparison
Compare OESX & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OESX
- CYCC
- Stock Information
- Founded
- OESX 1996
- CYCC 1992
- Country
- OESX United States
- CYCC Malaysia
- Employees
- OESX N/A
- CYCC N/A
- Industry
- OESX Building Products
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- OESX Consumer Discretionary
- CYCC Health Care
- Exchange
- OESX Nasdaq
- CYCC Nasdaq
- Market Cap
- OESX 21.6M
- CYCC 17.5M
- IPO Year
- OESX 2007
- CYCC N/A
- Fundamental
- Price
- OESX $7.26
- CYCC $7.12
- Analyst Decision
- OESX Strong Buy
- CYCC
- Analyst Count
- OESX 2
- CYCC 0
- Target Price
- OESX $17.50
- CYCC N/A
- AVG Volume (30 Days)
- OESX 20.8K
- CYCC 86.9K
- Earning Date
- OESX 11-05-2025
- CYCC 08-13-2025
- Dividend Yield
- OESX N/A
- CYCC N/A
- EPS Growth
- OESX N/A
- CYCC N/A
- EPS
- OESX N/A
- CYCC N/A
- Revenue
- OESX $79,389,000.00
- CYCC $10,000.00
- Revenue This Year
- OESX $6.63
- CYCC $137.21
- Revenue Next Year
- OESX $13.51
- CYCC N/A
- P/E Ratio
- OESX N/A
- CYCC N/A
- Revenue Growth
- OESX N/A
- CYCC N/A
- 52 Week Low
- OESX $5.50
- CYCC $3.08
- 52 Week High
- OESX $10.35
- CYCC $597.60
- Technical
- Relative Strength Index (RSI)
- OESX 60.94
- CYCC 41.06
- Support Level
- OESX $7.03
- CYCC $7.30
- Resistance Level
- OESX $7.50
- CYCC $8.82
- Average True Range (ATR)
- OESX 0.54
- CYCC 0.63
- MACD
- OESX 0.07
- CYCC 0.03
- Stochastic Oscillator
- OESX 79.81
- CYCC 17.87
About OESX Orion Energy Systems Inc.
Orion Energy Systems Inc is engaged in light-emitting diode lighting systems, wireless Internet of Things-enabled control solutions, project engineering, energy project management design, maintenance services, and turnkey electric vehicle charging stations and related installation services to commercial and industrial businesses, and federal and local governments, predominantly in North America. The group has three segments: the Orion lighting segment, the Orion maintenance segment, and the Orion electric vehicle charging segment. It generates the majority of its revenue from the Orion lighting segment, which develops and sells lighting products and provides construction and engineering services for Orion's commercial lighting and energy management systems.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.